# Study Evaluating Dexketoprofen Trometamol/Tramadol Hydrochloride Analgesic Efficacy in Acute Low Back Pain

> **NCT05170841** · PHASE4 · COMPLETED · sponsor: **Menarini International Operations Luxembourg SA** · enrollment: 538 (actual)

## Conditions studied

- Low Back Pain

## Interventions

- **DRUG:** Dexketoprofen Trometamol 25 mg/Tramadol Hydrochloride 75 mg
- **DRUG:** Tramadol Hydrochloride 100 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05170841
- **Lead sponsor:** Menarini International Operations Luxembourg SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-17
- **Primary completion:** 2022-05-04
- **Final completion:** 2022-05-04
- **Target enrollment:** 538 (ACTUAL)
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05170841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05170841, "Study Evaluating Dexketoprofen Trometamol/Tramadol Hydrochloride Analgesic Efficacy in Acute Low Back Pain". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05170841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*